{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T08:55:38Z","timestamp":1776070538964,"version":"3.50.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jiph.2026.103189","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:48:23Z","timestamp":1772264903000},"page":"103189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Surveillance of HIV-1 drug resistance in Tanzania across the pre- and post-dolutegravir eras: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8312-0643","authenticated-orcid":false,"given":"Belinda J.","family":"Njiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George M.","family":"Bwire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2026.103189_bib1","unstructured":"Global HIV & AIDS statistics \u2014 Fact sheet, 2024. Accessed: Jan. 20, 2026. [Online]. Available: \u3008https:\/\/www.unaids.org\/en\/resources\/fact-sheet\u3009."},{"key":"10.1016\/j.jiph.2026.103189_bib2","unstructured":"National Bureau of Statistics, Tanzania HIV Impact Survey 2022-2023. Accessed: Feb. 01, 2024. [Online]. Available: \u3008https:\/\/www.nbs.go.tz\/index.php\/en\/census-surveys\/health-statistics\/hiv-and-malaria-survey\/932-the-tanzania-hiv-impact-survey-2022-2023-summary-sheet\u3009."},{"key":"10.1016\/j.jiph.2026.103189_bib3","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1097\/QAD.0000000000002983","article-title":"The Joint United Nations Programme on HIV\/AIDS 95-95-95 targets: worldwide clinical and cost benefits of generic manufacture","volume":"35","author":"Heath","year":"2021","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.jiph.2026.103189_bib4","first-page":"451","article-title":"Progress towards the United Nations 90-90-90 and 95-95-95 targets: The experience in British Columbia, Canada","volume":"321","author":"Lima","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.jiph.2026.103189_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/HIV.S32321","article-title":"Quality of life of people living with HIV and AIDS and antiretroviral therapy","volume":"4","author":"Oguntibeju","year":"2012","journal-title":"HIV\/AIDS Res Palliat Care"},{"issue":"5","key":"10.1016\/j.jiph.2026.103189_bib6","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jama.2018.21167","article-title":"HIV viral load and transmissibility of HIV infection undetectable equals untransmittable","volume":"321","author":"Eisinger","year":"2019","journal-title":"JAMA J Am Med Assoc"},{"issue":"4","key":"10.1016\/j.jiph.2026.103189_bib7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3390\/microbiolres12040062","article-title":"Development of HIV drug resistance in a cohort of adults on first-line antiretroviral therapy in Tanzania during the stavudine era","volume":"12","author":"Sangeda","year":"2021","journal-title":"Microbiol Res"},{"issue":"10","key":"10.1016\/j.jiph.2026.103189_bib8","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1093\/jac\/dkw218","article-title":"Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa","volume":"71","author":"Boender","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.jiph.2026.103189_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0232649","article-title":"Patterns of acquired HIV-1 drug resistance mutations and predictors of virological failure in Moshi, Northern Tanzania","volume":"15","author":"Mziray","year":"2020","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jiph.2026.103189_bib10","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1093\/jac\/dkw051","article-title":"HIV virological failure and drug resistance in a cohort of Tanzanian HIV-infected adults","volume":"71","author":"Hawkins","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.jiph.2026.103189_bib11","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1093\/jac\/dkz272","article-title":"Pre-Treatment and acquired HIV drug resistance in Dar es Salaam, Tanzania in the era of tenofovir and routine viral load monitoring","volume":"74","author":"Barabona","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiph.2026.103189_bib12","first-page":"1","article-title":"Antiretroviral drug use and HIV drug resistance in female sex workers in Tanzania and the Dominican Republic","volume":"138","author":"Grant-mcauley","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jiph.2026.103189_bib13","unstructured":"National AIDS Control Programme. The United Republic of Tanzania, HIV Treatment Guideline, 2019. Accessed: Mar. 03, 2023. [Online]. Available: \u3008https:\/\/differentiatedservicedelivery.org\/wp-content\/uploads\/national_guidelines_for_the_management_of_hiv_and_aids_2019.pdf\u3009."},{"key":"10.1016\/j.jiph.2026.103189_bib14","unstructured":"The United Republic of Tanzania, National Guidelines for Management of HIV and AIDS, 2019. Accessed: Mar. 03, 2023. [Online]. Available: \u3008https:\/\/differentiatedservicedelivery.org\/wp-content\/uploads\/national_guidelines_for_the_management_of_hiv_and_aids_2019.pdf\u3009."},{"key":"10.1016\/j.jiph.2026.103189_bib15","unstructured":"World Health Organization, HIV Drug Resistance Report 2021. Accessed: Feb. 28, 2023. [Online]. Available: \u3008https:\/\/www.who.int\/publications\/i\/item\/9789240038608\u3009."},{"issue":"8","key":"10.1016\/j.jiph.2026.103189_bib16","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3390\/v17081087","article-title":"The magnitude and patterns of acquired drug resistance mutations and circulating HIV-1 subtypes in HIV patients in Tanzania, a systematic review and meta-analysis","volume":"17","author":"Henerico","year":"2025","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.jiph.2026.103189_bib17","first-page":"148","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"20","author":"Moher","year":"2016","journal-title":"Rev Esp De Nutr Hum y Diet"},{"key":"10.1016\/j.jiph.2026.103189_bib18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jclinepi.2022.05.022","article-title":"Searching two or more databases decreased the risk of missing relevant studies: a metaresearch study","volume":"149","author":"Ewald","year":"2022","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"10.1016\/j.jiph.2026.103189_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-3156.2011.02877.x","article-title":"Trends in the uptake of voluntary counselling and testing for HIV in rural Tanzania in the context of the scale up of antiretroviral therapy","volume":"17","author":"Isingo","year":"2012","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.jiph.2026.103189_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkad010","article-title":"Emerging integrase strand transfer inhibitor drug resistance mutations among children and adults on ART in Tanzania: findings from a national representative HIV drug resistance survey","author":"Kamori","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiph.2026.103189_bib21","doi-asserted-by":"crossref","unstructured":"A. Yoshii, D.A. Plaut, K.A. McGraw, M.J. Anderson, and K.E. Wellik, Analysis of the reporting of search strategies in Cochrane systematic reviews, Jan. 2009. doi: 10.3163\/1536-5050.97.1.004.","DOI":"10.3163\/1536-5050.97.1.004"},{"key":"10.1016\/j.jiph.2026.103189_bib22","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ Publ Group"},{"key":"10.1016\/j.jiph.2026.103189_bib23","article-title":"How to read a funnel plot in a meta-analysis","author":"Sedgwick","year":"2015","journal-title":"BMJ Publ Group"},{"key":"10.1016\/j.jiph.2026.103189_bib24","unstructured":"G. Wells et al., The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Non-randomized Studies in Meta-Analysis. Accessed: Dec. 08, 2022. [Online]. Available: \u3008https:\/\/web.archive.org\/web\/20210716121605id_\/http:\/\/www3.med.unipmn.it\/dispense_ebm\/2009-2010\/Corso%20Perfezionamento%20EBM_Faggiano\/NOS_oxford.pdf\u3009."},{"issue":"2","key":"10.1016\/j.jiph.2026.103189_bib25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/jac\/dkab406","article-title":"Prevalence and patterns of HIV drug resistance in patients with suspected virological failure in North-Western Tanzania","volume":"77","author":"Henerico","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiph.2026.103189_bib26","article-title":"The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses","author":"Melsen","year":"2014","journal-title":"Black Publ Ltd"},{"issue":"10","key":"10.1016\/j.jiph.2026.103189_bib27","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1093\/jac\/dkz272","article-title":"Pre-Treatment and acquired HIV drug resistance in Dar es Salaam, Tanzania in the era of tenofovir and routine viral load monitoring","volume":"74","author":"Barabona","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.jiph.2026.103189_bib28","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1089\/aid.2014.0251","article-title":"Frequent detection of antiretroviral drug resistance in HIV-1-infected orphaned children followed at a donor-funded rural pediatric clinic in Dodoma, Tanzania","volume":"31","author":"Meini","year":"2015","journal-title":"AIDS Res Hum Retrovir"},{"issue":"2","key":"10.1016\/j.jiph.2026.103189_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032055","article-title":"Emergence of minor drug-resistant hiv-1 variants after triple antiretroviral prophylaxis for prevention of vertical hiv-1 transmission","volume":"7","author":"Hauser","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jiph.2026.103189_bib30","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1093\/jac\/dkac295","article-title":"Primary resistance against integrase strand transfer inhibitors in integrase strand transfer inhibitor-naive patients failing first- and second-line ART in Tanzania","volume":"77","author":"Henerico","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.jiph.2026.103189_bib31","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1089\/aid.2011.0367","article-title":"Prevalence of drug resistance mutations and HIV type 1 subtypes in an HIV type 1-infected cohort in Rural Tanzania","volume":"29","author":"Masimba","year":"2013","journal-title":"AIDS Res Hum Retrovir"},{"issue":"1","key":"10.1016\/j.jiph.2026.103189_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227600","article-title":"High failure rates of protease inhibitor-based antiretroviral treatment in rural Tanzania \u2013 a prospective cohort study","volume":"15","author":"Bircher","year":"2020","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jiph.2026.103189_bib33","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/jac\/dkq234","article-title":"Drug resistance is widespread among children who receive long-term antiretroviral treatment at a rural Tanzanian hospital","volume":"65","author":"Bratholm","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jiph.2026.103189_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-47795-1","article-title":"High viral suppression and detection of dolutegravir-resistance associated mutations in treatment-experienced Tanzanian adults living with HIV-1 in Dar es Salaam","volume":"13","author":"Bwire","year":"2023","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jiph.2026.103189_bib35","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-014-0567-3","article-title":"Durability of antiretroviral therapy and predictors of virologic failure among perinatally HIV-infected children in Tanzania: A four-year follow-up","volume":"14","author":"Dow","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"11","key":"10.1016\/j.jiph.2026.103189_bib36","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1089\/aid.2017.0025","article-title":"HIV resistance and prevention of mother-to-child transmission regimen in HIV-infected infants in Northern Tanzania","volume":"33","author":"Dow","year":"2017","journal-title":"AIDS Res Hum Retrovir"},{"issue":"6","key":"10.1016\/j.jiph.2026.103189_bib37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/INF.0000000000002288","article-title":"HIV-1 drug resistance and virologic outcomes among tanzanian youth living with HIV","volume":"38","author":"Dow","year":"2019","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.jiph.2026.103189_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240890","article-title":"Antiretroviral drug use and HIV drug resistance in female sex workers in Tanzania and the Dominican Republic","volume":"15","author":"Grant-McAuley","year":"2020","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jiph.2026.103189_bib39","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1093\/jac\/dkw051","article-title":"HIV virological failure and drug resistance in a cohort of Tanzanian HIV-infected adults","volume":"71","author":"Hawkins","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.jiph.2026.103189_bib40","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1093\/jac\/dkac295","article-title":"Primary resistance against integrase strand transfer inhibitors in integrase strand transfer inhibitor-naive patients failing first- and second-line ART in Tanzania","volume":"77","author":"Henerico","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.jiph.2026.103189_bib41","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/jac\/dkab406","article-title":"Prevalence and patterns of HIV drug resistance in patients with suspected virological failure in North-Western Tanzania","volume":"77","author":"Henerico","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiph.2026.103189_bib42","article-title":"Virological efficacy and emergence of drug resistance in adults on antiretroviral treatment in rural Tanzania","volume":"9","author":"Naman","year":"2009","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.jiph.2026.103189_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023091","article-title":"HIV drug resistance (HIVDR) in antiretroviral therapy-na\u00efve patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high","volume":"6","author":"Kasang","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jiph.2026.103189_bib44","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/jpids\/piad040","article-title":"Factors Associated With Viral Suppression and Drug Resistance in Children and Adolescents Living With HIV in Care and Treatment Programs in Southern Tanzania","volume":"12","author":"Khamadi","year":"2023","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"1","key":"10.1016\/j.jiph.2026.103189_bib45","article-title":"Prevalence of human immunodeficiency virus drug resistance and factors associated with high viral load among adolescents on antiretroviral therapy in Dar Es Salaam, Tanzania","volume":"25","author":"Maseke","year":"2024","journal-title":"HIV Res Clin Pract"},{"issue":"7","key":"10.1016\/j.jiph.2026.103189_bib46","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3855\/jidc.3879","article-title":"Clinical and virological response to antiretroviral drugs among HIV patients on first-line treatment in Dar-es-Salaam, Tanzania","volume":"8","author":"Mosha","year":"2014","journal-title":"J Infect Dev Ctries"},{"issue":"1","key":"10.1016\/j.jiph.2026.103189_bib47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/QAD.0000000000001273","article-title":"Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern","volume":"31","author":"Muri","year":"2017","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.jiph.2026.103189_bib48","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1086\/522991","article-title":"Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania","volume":"45","author":"Ramadhani","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.jiph.2026.103189_bib49","first-page":"3476","article-title":"Prevalence of pretreatment HIV drug resistance in Mwanza, Tanzania","volume":"73","author":"Rudovick","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.jiph.2026.103189_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281528","article-title":"HIV virologic response, patterns of drug resistance mutations and correlates among adolescents and young adults: A cross-sectional study in Tanzania","volume":"18","author":"Rugemalila","year":"2023","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jiph.2026.103189_bib51","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/jac\/dkaf125","article-title":"Viral suppression after failure of PI-based ART among adolescents and youths with and without drug resistance mutations: a longitudinal analysis in Tanzania","volume":"80","author":"Rugemalila","year":"2025","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.jiph.2026.103189_bib52","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/jac\/dku087","article-title":"HIV-1 drug mutations in children from northern Tanzania","volume":"69","author":"Shao","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jiph.2026.103189_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-13-439","article-title":"HIV-1 drug resistance in recently HIV-infected pregnant mother\u2019s na\u00efve to antiretroviral therapy in Dodoma urban, Tanzania","volume":"13","author":"Vairo","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiph.2026.103189_bib54","unstructured":"The path that ends AIDS: UNAIDS Global AIDS Update 2023. Accessed: Mar. 16, 2024. [Online]. Available: \u3008https:\/\/www.unaids.org\/en\/resources\/documents\/2023\/global-aids-update-2023\u3009."},{"key":"10.1016\/j.jiph.2026.103189_bib55","unstructured":"UNAIDS, Fact Sheet 2021 Global HIV Statistics, Ending the AIDS epidemic, no. June, pp. 1\u20133, 2021, Accessed: Feb. 03, 2026. [Online]. Available: \u3008https:\/\/www.unaids.org\/en\/resources\/fact-sheet\u3009."},{"key":"10.1016\/j.jiph.2026.103189_bib56","unstructured":"WHO, HIV Drug Resistance Report 2021, 2021. Accessed: Mar. 12, 2024. [Online]. Available: \u3008https:\/\/www.who.int\/publications\/i\/item\/9789240038608\u3009."},{"issue":"9849","key":"10.1016\/j.jiph.2026.103189_bib57","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(12)61038-1","article-title":"Global trends in antiretroviral resistance in treatment-na\u00efve individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: A global collaborative study and meta-regression analysis","volume":"380","author":"Gupta","year":"2012","journal-title":"Lancet"},{"issue":"46","key":"10.1016\/j.jiph.2026.103189_bib58","doi-asserted-by":"crossref","first-page":"E1350","DOI":"10.1503\/cmaj.180311","article-title":"Risk of sexual transmission of human immunodeficiency virus with antiretroviral therapy, suppressed viral load and condom use: a systematic review","volume":"190","author":"LeMessurier","year":"2018","journal-title":"CMAJ"},{"issue":"11","key":"10.1016\/j.jiph.2026.103189_bib59","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/QAD.0b013e32832b7dca","article-title":"Sexual transmission of HIV according to viral load and antiretroviral therapy: Systematic review and meta-analysis","volume":"23","author":"Attia","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jiph.2026.103189_bib60","article-title":"Management of Virologic Failure and HIV Drug Resistance","author":"McCluskey","year":"2019","journal-title":"W B Saunders"},{"issue":"1","key":"10.1016\/j.jiph.2026.103189_bib61","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/jac\/dkw358","article-title":"HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa","volume":"72","author":"Steegen","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.jiph.2026.103189_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0145772","article-title":"HIV-1 drug resistance mutations: Potential applications for point-of-care Genotypic resistance testing","volume":"10","author":"Rhee","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jiph.2026.103189_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2019.100239","article-title":"Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: a cohort study in Kenya","volume":"18","author":"Beck","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"November","key":"10.1016\/j.jiph.2026.103189_bib64","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.2147\/IDR.S337485","article-title":"Genetic diversity and acquired drug resistance mutations detected by deep sequencing in virologic failures among antiretroviral treatment experienced human immunodeficiency virus-1 patients in a pastoralist region of Ethiopia","volume":"14","author":"Tachbele","year":"2021","journal-title":"Infect Drug Resist"},{"issue":"1","key":"10.1016\/j.jiph.2026.103189_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12981-021-00393-5","article-title":"Acquired HIV drug resistance and virologic monitoring in a HIV hyper-endemic setting in KwaZulu-Natal Province, South Africa","volume":"18","author":"Chimukangara","year":"2021","journal-title":"AIDS Res Ther"},{"issue":"10","key":"10.1016\/j.jiph.2026.103189_bib66","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/tmi.13131","article-title":"HIV-1 drug resistance testing at second-line regimen failure in Arua, Uganda: avoiding unnecessary switch to an empiric third-line","volume":"23","author":"Fily","year":"2018","journal-title":"Trop Med Int Health"},{"issue":"7","key":"10.1016\/j.jiph.2026.103189_bib67","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/cid\/ciy589","article-title":"Evolution of protease inhibitor resistance in human immunodeficiency virus type 1 infected patients failing protease inhibitor monotherapy as second-line therapy in low-income countries: an observational analysis within the EARNEST randomized trial","volume":"68","author":"Thompson","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.jiph.2026.103189_bib68","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/QAD.0000000000002854","article-title":"Pre-treatment integrase inhibitor resistance is uncommon in antiretroviral therapy-naive individuals with HIV-1 subtype A1 and D infections in Uganda","volume":"35","author":"McCluskey","year":"2021","journal-title":"Aids"},{"issue":"September","key":"10.1016\/j.jiph.2026.103189_bib69","first-page":"1","article-title":"Prevalence of resistance mutations associated with integrase inhibitors in therapy-naive HIV-positive patients in Baoding, Hebei province, China","volume":"13","author":"Fan","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.jiph.2026.103189_bib70","doi-asserted-by":"crossref","DOI":"10.1177\/23259582221109613","article-title":"Adherence, effectiveness and safety of dolutegravir based antiretroviral regimens among HIV infected children and adolescents in Tanzania","volume":"21","author":"Mutagonda","year":"2022","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"10.1016\/j.jiph.2026.103189_bib71","doi-asserted-by":"crossref","DOI":"10.1177\/23259582221084543","article-title":"Adherence to antiretroviral therapy and associated factors among people living with HIV following the introduction of dolutegravir based regimens in Dar es Salaam, Tanzania","volume":"21","author":"Kilapilo","year":"2022","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"2","key":"10.1016\/j.jiph.2026.103189_bib72","first-page":"83","article-title":"Update on HIV-1 diversity in Africa: a decade in review","volume":"14","author":"Lihana","year":"2012","journal-title":"AIDS Rev"},{"issue":"11","key":"10.1016\/j.jiph.2026.103189_bib73","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1089\/aid.2009.0110","article-title":"Antiretroviral drug-resistant mutations at baseline and at time of failure of antiretroviral therapy in HIV type 1-coinfected TB patients","volume":"25","author":"Rajesh","year":"2009","journal-title":"AIDS Res Hum Retrovir"},{"issue":"5","key":"10.1016\/j.jiph.2026.103189_bib74","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1128\/JVI.73.5.4393-4403.1999","article-title":"Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya","volume":"73","author":"Neilson","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.jiph.2026.103189_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.11604\/pamj.2021.38.335.26357","article-title":"Human immunodeficiency virus (HIV) type 1 genetic diversity in hiv positive individuals on antiretroviral therapy in a cross sectional study conducted in Teso, Western Kenya","volume":"38","author":"Adhiambo","year":"2021","journal-title":"Pan Afr Med J"},{"issue":"12","key":"10.1016\/j.jiph.2026.103189_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pathogens9121072","article-title":"Molecular epidemiology of HIV-1 in african countries: A comprehensive overview","volume":"9","author":"Giovanetti","year":"2020","journal-title":"Pathogens"},{"issue":"12","key":"10.1016\/j.jiph.2026.103189_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10121535","article-title":"Factors associated with HIV drug resistance in Dar es Salaam, Tanzania: analysis of a complex adaptive system","volume":"10","author":"Kiekens","year":"2021","journal-title":"Pathogens"},{"issue":"9","key":"10.1016\/j.jiph.2026.103189_bib78","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1007\/s10461-019-02443-6","article-title":"Microfinance interventions and HIV treatment outcomes: a synthesizing conceptual framework and systematic review","volume":"23","author":"Nadkarni","year":"2019","journal-title":"AIDS Behav"},{"issue":"7","key":"10.1016\/j.jiph.2026.103189_bib79","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1007\/s10461-010-9697-9","article-title":"Matching social support to individual needs: a community-based intervention to improve HIV treatment adherence in a resource-poor setting","volume":"15","author":"Mu\u00f1oz","year":"2011","journal-title":"AIDS Behav"},{"key":"10.1016\/j.jiph.2026.103189_bib80","doi-asserted-by":"crossref","unstructured":"M. Arrivillaga, J.P. Salcedo, and M. P\u00e9rez, The imea project: An intervention based on microfinance, entrepreneurship, and adherence to treatment for women with hiv\/aids living in poverty, 2014. doi: 10.1521\/aeap.2014.26.5.398.","DOI":"10.1521\/aeap.2014.26.5.398"},{"issue":"2","key":"10.1016\/j.jiph.2026.103189_bib81","doi-asserted-by":"crossref","first-page":"100","DOI":"10.47429\/lmo.2022.12.2.100","article-title":"HIV-1 drug resistance mutations and their clinical implications in South Korea","volume":"12","author":"Yun","year":"2022","journal-title":"Lab Med Online"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034126000614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034126000614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T08:03:53Z","timestamp":1776067433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034126000614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1876034126000614"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2026.103189","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surveillance of HIV-1 drug resistance in Tanzania across the pre- and post-dolutegravir eras: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2026.103189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"103189"}}